Articles with public access mandates - Scott C. GarmanLearn more
Available somewhere: 26
GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings
A Caciotti, SC Garman, Y Rivera-Colón, E Procopio, S Catarzi, L Ferri, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (7), 782-790, 2011
Mandates: US National Institutes of Health, Fondazione Telethon, Italy
CATALYTIC MECHANISM OF HUMAN Α-GALACTOSIDASE
AI Guce, NE Clark, EN Salgado, DR Ivanen, AA Kulminskaya, H Brumer, ...
Journal of Biological Chemistry 285 (6), 3625-3632, 2010
Mandates: US National Institutes of Health
The structure of human GALNS reveals the molecular basis for mucopolysaccharidosis IV A
Y Rivera-Colón, EK Schutsky, AZ Kita, SC Garman
Journal of molecular biology 423 (5), 736-751, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
DP Germain, E Brand, A Burlina, F Cecchi, SC Garman, J Kempf, ...
Molecular genetics & genomic medicine 6 (4), 492-503, 2018
Mandates: US National Institutes of Health, Government of Spain
The alpha-galactosidase A p. Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies
S Ferreira, A Ortiz, DP Germain, M Viana-Baptista, A Caldeira-Gomes, ...
Molecular genetics and metabolism 114 (2), 248-258, 2015
Mandates: US National Institutes of Health, Government of Spain
The molecular basis of pharmacological chaperoning in human α-galactosidase
AI Guce, NE Clark, JJ Rogich, SC Garman
Chemistry & biology 18 (12), 1521-1526, 2011
Mandates: US National Institutes of Health
Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution
RW Herbst, A Guce, PA Bryngelson, KA Higgins, KC Ryan, DE Cabelli, ...
Biochemistry 48 (15), 3354-3369, 2009
Mandates: US National Institutes of Health
The 1.9 Å structure of human α-N-acetylgalactosaminidase: the molecular basis of Schindler and Kanzaki diseases
NE Clark, SC Garman
Journal of molecular biology 393 (2), 435-447, 2009
Mandates: US National Institutes of Health
Pharmacological chaperones for human α-N-acetylgalactosaminidase
NE Clark, MC Metcalf, D Best, GWJ Fleet, SC Garman
Proceedings of the National Academy of Sciences 109 (43), 17400-17405, 2012
Mandates: US National Institutes of Health
Functional studies of new GLA gene mutations leading to conformational Fabry disease
C Filoni, A Caciotti, L Carraresi, C Cavicchi, R Parini, D Antuzzi, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1802 (2), 247-252, 2010
Mandates: US National Institutes of Health
Human acid sphingomyelinase structures provide insight to molecular basis of Niemann–Pick disease
YF Zhou, MC Metcalf, SC Garman, T Edmunds, H Qiu, RR Wei
Nature communications 7 (1), 13082, 2016
Mandates: US National Institutes of Health
Unlocking a caged lysosomal protein from a polymeric nanogel with a pH trigger
MR Molla, T Marcinko, P Prasad, D Deming, SC Garman, ...
Biomacromolecules 15 (11), 4046-4053, 2014
Mandates: US National Institutes of Health
Malectin/Malectin-like domain-containing proteins: a repertoire of cell surface molecules with broad functional potential
H Yang, D Wang, L Guo, H Pan, R Yvon, S Garman, HM Wu, AY Cheung
The Cell Surface 7, 100056, 2021
Mandates: US National Science Foundation, US National Institutes of Health
Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma
S Ferreira, C Auray-Blais, M Boutin, P Lavoie, JP Nunes, E Martins, ...
Clinica Chimica Acta 447, 96-104, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases
IB Tomasic, MC Metcalf, AI Guce, NE Clark, SC Garman
Journal of Biological Chemistry 285 (28), 21560-21566, 2010
Mandates: US National Institutes of Health
CaMKII binds both substrates and activators at the active site
C Özden, R Sloutsky, T Mitsugi, N Santos, E Agnello, C Gaubitz, J Foster, ...
Cell reports 40 (2), 2022
Mandates: US National Institutes of Health, Japan Science and Technology Agency, Human …
Adaptor-dependent degradation of a cell-cycle regulator uses a unique substrate architecture
KL Rood, NE Clark, PR Stoddard, SC Garman, P Chien
Structure 20 (7), 1223-1232, 2012
Mandates: US National Institutes of Health
Nickel superoxide dismutase: structural and functional roles of His1 and its H-bonding network
KC Ryan, AI Guce, OE Johnson, TC Brunold, DE Cabelli, SC Garman, ...
Biochemistry 54 (4), 1016-1027, 2015
Mandates: US Department of Energy, US National Institutes of Health
Characterization of CaMKIIα holoenzyme stability
AP Torres‐Ocampo, C Özden, A Hommer, A Gardella, E Lapinskas, ...
Protein Science 29 (6), 1524-1534, 2020
Mandates: US National Institutes of Health
Proteolytic activation of human cathepsin A
N Kolli, SC Garman
Journal of Biological Chemistry 289 (17), 11592-11600, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program